跳至主要内容
临床试验/NCT02309398
NCT02309398已完成不适用

Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Atrial Fibrillation

Beijing Institute of Heart, Lung and Blood Vessel Diseases1 个研究点 分布在 1 个国家目标入组 67,028 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
67,028
试验地点
1
主要终点
The overall composite of six performance measures for AF care

研究概览

简要总结

The purpose of this study is to develop and implement quality improvement programs for the treatment of atrial fibrillation (AF) in China based on the successful experience of the AHA-Get with the Guidelines program. This program will use data collection, analysis, feedback, and process improvement to extend the use of evidence-based guidelines throughout the healthcare system and improve patient care of atrial fibrillation.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Hospitalized patients with discharge diagnosis as atrial fibrillation in 150 tertiary and 100 secondary hospitals.

排除标准

  • 未提供

结局指标

主要结局

The overall composite of six performance measures for AF care

时间窗: Duration of hospital stay, an expected average of 1 week

Performance measures for AF care including: 1. Proportion of patients received assessment of thromboembolic risk factors 2. Proportion of patients discharged on warfarin or other anticoagulant drug 3. Proportion of patients discharged on warfarin who have PT/INR follow-up planned prior to hospital discharge 4. Proportion of patients with left ventricular systolic dysfunction prescribed an ACEI or ARB at hospital discharge 5. Proportion of patients with left ventricular systolic dysfunction prescribed a beta blocker at hospital discharge 6. Proportion of patients with either coronary artery disease, cerebrovascular accident/transient ischemic attack, peripheral vascular disease or diabetes who were prescribed a statin at hospital discharge

次要结局

未报告次要终点

研究者

发起方
Beijing Institute of Heart, Lung and Blood Vessel Diseases
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dong ZHAO

Principal Investigator

Beijing Institute of Heart, Lung and Blood Vessel Diseases

研究点 (1)

Loading locations...

相似试验

CCC Project - Atrial Fibrillation | 临床试验